Risankizumab: A pilot study of short-term effectiveness and safety in real clinical practice.

Ruiz-Villaverde, Ricardo; Ruiz-Carrascosa, Jose Carlos; Galán-Gutierrez, Manuel; Armario-Hita, Jose Carlos

Ruiz-Villaverde, Ricardo; Ruiz-Carrascosa, Jose Carlos; Galán-Gutierrez, Manuel; Armario-Hita, Jose Carlos.

Afiliação

Ruiz-Villaverde R; Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
Ruiz-Carrascosa JC; Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
Galán-Gutierrez M; Department of Dermatology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Armario-Hita JC; Department of Dermatology, Hospital Universitario Puerto Real, Cádiz, Spain.

Dermatol Ther ; 34(1): e14711, 2021 01.

Article em En | MEDLINE | ID: mdl-33368889

Assuntos

Anticorpos Monoclonais; Psoríase; Humanos; Projetos Piloto; Psoríase/diagnóstico; Psoríase/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies / Evaluation_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google